Skip to content

Clinical trials

Phase 3 trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Country / region: Norway Clear all

1,131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200017
200114
200226
200338
200438
200550
200654
200751
200854
200939
201035
201143
201238
201353
201442
201535
201633
201744
201841
201945
202045
202164
202251
202335
202444
202543
202632

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed735
Active, not recruiting122
Recruiting119
Terminated111
Unknown status29
Enrolling by invitation6
Withdrawn4
Not yet recruiting4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals85
AstraZeneca65
Boehringer Ingelheim63
Sanofi57
Hoffmann-La Roche55
GlaxoSmithKline49
Novo Nordisk A/S45
Bristol-Myers Squibb40
Pfizer36
Bayer33

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 255
Multiple Myeloma38
Neoplasms32
Pulmonary Disease, Chronic Obstructive32
Diabetes Mellitus30
Hypercholesterolemia30
Breast Neoplasms28
Carcinoma, Non-Small-Cell Lung26
Melanoma24
Ovarian Neoplasms24

Trials

Showing 76 to 100 of 1,131. Each trial links to its page on Pharma Observatory.

1,031 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.